Navigation Links
New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity

PALO ALTO, Calif., March 31, 2008 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 200-MS Series of ion trap mass spectrometers for GC/MS (gas chromatography/mass spectrometry). GC/MS is used by analytical chemists for the detection and characterization of compounds in samples from a variety of applications including environmental, toxicology, food safety and agriculture. The series comprises three instruments (210-MS, 220-MS and 240-MS) for use in applications from routine analysis to advanced research.

Both the 240-MS and the 220-MS are delivered with Varian's top of the line 450-GC gas chromatograph to ensure the highest level of analytical performance. The 240-MS delivers the highest full scan sensitivity available. A choice of ionization modes and MS/MS scanning options allows accurate identification and quantification of trace analytes even in the presence of complex matrices. This robust instrument is easy to maintain, making it equally suitable for use in both research and high-throughput environments.

The 220-MS is a flexible instrument that offers excellent analytical capabilities with CI (chemical ionization) and MS/MS options for increased sensitivity and selectivity in a range of configurations. The 210-MS, available with the new 431-GC, is an entry level GC/MS designed for routine, high-throughput laboratories that require sensitive detection for gas chromatography.

"The 200-MS series offers a range of choices for analytical chemists to match their specific requirements," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Varian has a complete GC/MS solution for every user from researchers interested in detailed structural analysis to novice operators running samples in a high throughput analytical laboratory."

For more technical information about Varian's GC/MS instrumentation, please visit

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
2. Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
3. Varian, Inc. CEO to Speak at JPMorgan Healthcare Conference
4. Varian, Inc. Acquires Analogix Business
5. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
6. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
7. Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced Any and All Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009
8. Supporting Healthy Marriage Program Offered by Montefiore
9. SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc.
10. 2008 Social Security Report Offers Dire Warning
11. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
Post Your Comments:
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL LEADERSHIP: ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November 24, ... patients and their families, shaped my desire to improve the system of care. I ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Kevin Day, local family chiropractor in ... less this holiday season. During the Indiana winter months, Vitamin D deficiency can ... team at AlignLife want to help provide the tools needed to combat it this ...
(Date:11/24/2015)... ... 2015 , ... All her life, Don Peck’s mother wondered if she was a descendant of ... been. After a 25-year search for information, Don and his aunt discovered that she ... name. Turns out, it was Don’s father who was descended from not one, but ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... engineer of patented products, announces Fragrance by Marcelle, a cosmetic invention which offers ... Perfume & Fragrance Manufacturing Market in the US is worth $3 billion annually," ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... of the Business Action on Health Awards, bestowed annually to the world’s best ... five commended companies at Global Health Council’s Landscape Symposium held in Washington D.C ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -based Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ) ... and dispensing of novel compounded pharmaceuticals.  The company,s ... ophthalmology, urology, sinus and integrative medicine.  Imprimis dispenses ... facilities located in California , ... Jersey and Pennsylvania.  For more information ...
(Date:11/24/2015)... NEW YORK , Nov. 24, 2015  Eyewear brand ... sunglasses in collaboration with U2 lead singer and activist Bono ... campaign to prevent vision impairment and blindness in more than ... --> Revo will donate $10 from the sale ... Visibility" collection, up to a total of $10 million to ...
(Date:11/24/2015)... Nov. 24, 2015 Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Dahiyat , Ph.D., president and chief executive officer, will ... , 2015 Piper Jaffray Healthcare Conference Date: Tuesday, December ... New York, NY     , Oppenheimer ...
Breaking Medicine Technology: